Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Benchmark Holdings Plc

Healthcare GB BMK

NoneGBX
0.00(0%)

Last update at 2025-09-02T16:00:06.850437Z

Day Range

--
LowHigh

52 Week Range

33.0046.91
LowHigh

Fundamentals

  • Previous Close 20.65
  • Market Cap262.47M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA23.02M
  • Revenue TTM169.48M
  • Revenue Per Share TTM0.23
  • Gross Profit TTM 83.13M
  • Diluted EPS TTM-0.02

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Type yearly yearly yearly yearly yearly
Date 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Income before tax -12.69400M -23.17700M -9.17900M -22.57100M -73.30400M
Minority interest -1.58200M -1.63600M -1.31500M 6.31M 6.14M
Net income -23.14600M -30.45100M -11.57600M -22.77500M -73.29100M
Selling general administrative - - - - 0.21M
Selling and marketing expenses - - - - -
Gross profit 86.75M 83.13M 65.58M 54.96M 66.00M
Reconciled depreciation 37.21M 39.06M 24.64M 28.54M 83.31M
Ebit -0.46500M -4.75600M -1.00800M -7.67800M -64.95000M
Ebitda 36.74M 34.30M 23.63M 20.86M 18.36M
Depreciation and amortization 37.21M 39.06M 24.64M 28.54M 83.31M
Non operating income net other - - - - -
Operating income -5.31600M -4.75600M -1.00800M -7.67800M -64.95000M
Other operating expenses 170.86M 165.56M 129.35M 114.47M 187.60M
Interest expense 10.50M 11.42M 7.99M 12.78M 6.09M
Tax provision 3.37M 7.27M 2.40M 0.20M -0.01300M
Interest income 0.63M 4.74M 4.18M 0.10M 0.37M
Net interest income -9.87400M -15.31600M -3.80200M -8.27500M -5.72800M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 3.37M 7.27M 2.40M 0.20M -0.01300M
Total revenue 169.48M 158.28M 125.06M 105.56M 127.34M
Total operating expenses 88.13M 90.41M 69.87M 63.87M 126.25M
Cost of revenue 82.73M 75.15M 59.48M 50.60M 61.35M
Total other income expense net -7.37800M -18.42100M -8.17100M -14.89300M -8.35400M
Discontinued operations - - - -9.17400M -23.95900M
Net income from continuing ops -16.05900M -30.45100M -11.57600M -22.77500M -73.29100M
Net income applicable to common shares - -32.08700M -12.89100M -32.92300M -83.85700M
Preferred stock and other adjustments - - - - -
Breakdown 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Type yearly yearly yearly yearly yearly
Date 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Total assets 471.30M 526.57M 481.99M 489.04M 503.38M
Intangible assets 103.59M 130.54M 130.34M 145.76M 167.16M
Earning assets - - - - -
Other current assets - 56.38M 46.50M 39.37M 16.02M
Total liab 188.68M 203.29M 202.39M 193.59M 192.91M
Total stockholder equity 276.40M 313.40M 271.71M 289.13M 304.33M
Deferred long term liab - 27.24M 25.80M 21.97M 18.71M
Other current liab 28.37M 11.84M 6.20M 4.34M 13.74M
Common stock 0.74M 0.70M 0.67M 0.67M 0.56M
Capital stock 0.74M 0.70M 0.67M 0.67M 0.56M
Retained earnings 183.49M -185.13600M -154.23100M -142.17000M -110.91600M
Other liab - 36.99M 29.14M 34.40M 40.75M
Good will 102.49M 114.72M 98.70M 101.25M 108.58M
Other assets - 48.12M 47.05M 38.59M 31.18M
Cash 36.52M 36.40M 39.46M 71.61M 16.05M
Cash and equivalents - - - - -
Total current liabilities 75.08M 73.26M 63.52M 55.38M 52.21M
Current deferred revenue - - - - -
Net debt 65.47M 73.74M 80.93M 37.55M 87.14M
Short term debt 20.05M 17.09M 10.65M 5.34M 3.23M
Short long term debt 8.48M 5.57M 1.61M 2.86M 3.10M
Short long term debt total 102.00M 110.14M 120.39M 109.16M 103.19M
Other stockholder equity 92.18M 497.83M 425.28M 430.63M 414.69M
Property plant equipment - 108.93M 104.31M 75.95M 88.90M
Total current assets 150.03M 148.37M 124.03M 145.75M 122.79M
Long term investments - - - - 3.48M
Net tangible assets - 95.37M 68.48M 64.09M 47.29M
Short term investments - - - - -
Net receivables 24.85M 40.50M 34.36M 28.43M 52.08M
Long term debt 73.66M 78.28M 94.79M 95.86M 99.50M
Inventory 52.85M 55.59M 38.07M 34.77M 38.63M
Accounts payable 26.66M 44.32M 46.67M 45.69M 35.23M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -28.26500M
Additional paid in capital - - - - -
Common stock total equity - - - 0.67M 0.56M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 21.98M 24.01M 24.61M 20.33M 15.95M
Deferred long term asset charges - - - - -
Non current assets total 321.27M 378.20M 357.96M 343.29M 380.59M
Capital lease obligations 19.86M 26.29M 23.99M 10.44M 0.59M
Long term debt total - - - - -
Breakdown 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Type yearly yearly yearly yearly yearly
Date 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Investments -5.27200M 1.17M -0.56900M 6.41M -1.07800M
Change to liabilities - 6.95M 5.55M 5.01M 3.97M
Total cashflows from investing activities - -11.21600M -23.09000M 30.38M -15.32100M
Net borrowings - -17.46800M -7.70800M -3.87400M 21.35M
Total cash from financing activities -12.32700M -6.92200M -14.66900M 30.13M 15.98M
Change to operating activities - 1.06M -5.42700M -0.26000M 0.26M
Net income -21.56400M -30.45100M -11.57600M -31.94900M -83.08000M
Change in cash 0.13M -3.06100M -32.14500M 55.55M -8.03900M
Begin period cash flow 36.40M 39.46M 71.61M 16.05M 24.09M
End period cash flow 36.52M 36.40M 39.46M 71.61M 16.05M
Total cash from operating activities 20.00M 10.81M 5.79M -4.05600M -9.21100M
Issuance of capital stock 13.02M 20.74M 0.75M 42.98M 0.00200M
Depreciation 37.21M 39.06M 24.64M 28.54M 83.31M
Other cashflows from investing activities - 0.12M 0.09M 1.49M 0.45M
Dividends paid - - - - -
Change to inventory 1.22M -11.50500M -8.98100M -3.73300M -10.86600M
Change to account receivables - -8.51100M -8.17800M 4.20M -12.51600M
Sale purchase of stock - - - - -
Other cashflows from financing activities -6.87700M 47.22M -12.31300M -2.70400M 87.21M
Change to netincome - 16.82M 5.98M 0.40M 21.08M
Capital expenditures 6.78M 12.72M 22.72M 11.41M 15.81M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -1.05700M -12.01200M -11.61200M 5.21M -19.15300M
Stock based compensation 1.00M 1.18M 0.83M 1.67M 1.18M
Other non cash items 7.73M 13.03M 6.54M 9.78M 7.47M
Free cash flow 13.22M -1.91100M -16.93100M -15.47000M -25.02500M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (GBX) Price (GBX) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
BMK
Benchmark Holdings Plc		 - -% - - - 1.55 0.94 1.91 9.26
HLN
Haleon PLC		 2.00 0.60% 336.00 20.24 18.94 2.95 2.02 3.68 14.19
HIK
Hikma Pharmaceuticals PLC		 13.00 0.88% 1495.00 9.73 9.03 0.85 1.45 1.53 6.07
HCM
HUTCHMED China Ltd		 1.25 0.74% 169.25 5.38 19.30 3.37 2.02 2.25 2.40
AGY
Allergy Therapeutics		 0.10 1.19% 8.50 - 106.38 11.72 159.47 12.12 -4.1496

Reports Covered

Stock Research & News

View All

Profile

Benchmark Holdings plc, together with its subsidiaries, engages in the provision of technical services, products, and specialist knowledge that supports the development of food and farming industries. It operates through Genetics, Advanced Nutrition, and Health segments. The Genetics segment offers sea bass and bream, salmon, and shrimp breeding technologies and production facilities to the harnesses industry to provide various genetic merit ova. The Advanced Nutrition segment manufactures and provides nutrition and health products to the aquaculture industry. The Health segment provides health products, including Ectosan Vet and CleanTreat medicinal sea lice solutions to the aquaculture market. The company operates in the United Kingdom, Norway, Vietnam, Iceland, the Faroe Islands, China, Ecuador, India, Canada, Greece, Chile, Turkey, rest of the Europe, and internationally. Benchmark Holdings plc was incorporated in 2000 and is headquartered in Sheffield, the United Kingdom.

Benchmark Holdings Plc

4 Park Square, Sheffield, United Kingdom, S35 2PH

Key Executives

Name Title Year Born
Mr. Trond Williksen CEO & Director 1963
Ms. Septima Maguire CFO & Director NA
Ms. Ruth Layton Co-Founder & Head of Benchmark Sustainability Science NA
Mr. Neil Robertson Head of Operations NA
Ms. Ivonne Maria Gloria Cantu Director of Investor Relations & Corp. Devel. and Head of Sustainability Working Group 1969
Ms. Jennifer Haddouk Company Sec. & Group Legal Counsel NA
Ms. Corina Holmes Group Head of People NA
Mr. Roland James Bonney Group Lead of Key Account Management 1964
Mr. David Babington Managing Director of Improve International NA
Mr. John Marshall Head of Health NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions